Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-14-026295

Options or other derivatives

  • Director acquired 7,920 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DRISCOLL FREDERICK W · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2014-07-02 Grant or award : show line 1 in the form Stock Option (Right to Buy) +7,920 7,920 D
Loading xslF345X03/rrd412921.xml…